The efficacy and safety of 0.01% bimatoprost ophthalmic solution compared with 0.1% tacrolimus ointment in patients with nonsegmental facial vitiligo was analyzed in this novel studied.
Strategies for the treatment of depigmented skin are reviewed in this study.
The prevalence of comorbidities in pediatric patients with alopecia areata was determined, using a large de-identified aggregated patient database.
Electrocautery needling may be a complement to conventional refractory vitiligo therapies thanks to its high repigmentation rate, simple operating procedure, and low therapeutic cost.
The relationship between long-term NB-UVB phototherapy and cardiovascular or cerebrovascular risk in patients with vitiligo was investigated.
Ruxolitinib cream at various doses led to repigmentation of vitiligo lesions at up to 52 weeks of treatment in patients with vitiligo.
Patients with chronic inflammatory skin diseases (CISD) are at increased risk for significant morbidity from herpes zoster.
Insufficiency of T-regulatory cells, which maintain immune system equilibrium and inhibit proinflammatory cell responses, may be a factor in the pathogenesis of MDD.
Many patients with vitiligo undergo multiple courses of phototherapy, which may raise concerns about their risk of photocarcinogenesis.
Researchers examined the relationship between vitiligo and the risk for psychiatric disorders such as anxiety, major depressive disorder, and manic disorders.
